HER2, estrogen receptor-negative metastatic hidradenocarcinoma: identification of TP53 mutation in both primary and cell-free DNA

HER2, estrogen receptor-negative metastatic hidradenocarcinoma: identification of TP53 mutation in both primary and cell-free DNA

Hidradenocarcinoma is an extremely rare cutaneous skin carcinoma which arise from the sweat gland. There are several report about potential targets in this rare disease including estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2). A 53-year-old man who presented with a slowly...

Full description

Bibliographic Details
Main Authors: Siho Kim, Jinhyun Cho, Won Park, Sang-Hee Choi, Woongyang Park, Kee-Taek Jang, Jeeyun Lee
Format: Article
Language:English
Published: Sungkyunkwan University School of Medi 2017-03-01
Series:Precision and Future Medicine
Subjects:
Hidradenocarcinoma
Metastatic disease
P53 mutation
Online Access:http://www.pfmjournal.org/upload/pdf/pfm-2017-00108.pdf

Internet

http://www.pfmjournal.org/upload/pdf/pfm-2017-00108.pdf

Similar Items